Concepedia

Keiichi Yotsumoto

KY

3

Publications

61

Citations

3

H-Index

2017

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Keiichi Yotsumoto is an author at Daiichi-Sankyo (Japan) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2017–2020

3

Publications

3

Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease

Katsushi Katayama, Ken J. Ishii, Hideki Terashima et al. · ACS Medicinal Chemistry Letters · 2020 · 27 citations · Full text

, , +14

Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines

Katsushi Katayama, Ken J. Ishii, Keiichi Yotsumoto et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 24 citations · Full text

, , +11

5‐Fluorouracil treatment alters the expression of intestinal transporters in rats

Keiichi Yotsumoto, Takeshi Akiyoshi, Naoki Wada et al. · Biopharmaceutics & Drug Disposition · 2017 · 10 citations

Rows per page

1–3 of 3